Key Takeaways
- • The CFTC approved Kalshi's application to list perpetual futures contracts (BTCPERP), marking the first regulatory authorization for perpetual futures trading in the United States, with the submission filed on May 28, 2026.
- • Kalshi achieved $1 billion in perpetual futures trading volume within one week of the U.S. launch, demonstrating significant market demand for the product.
- • CME Group, the dominant U.S. derivatives exchange, filed suit against the CFTC to block Kalshi's perpetual futures approval, arguing the contracts should be classified as swaps under Dodd-Frank rather than futures, which would subject them to different regulatory treatment.
- • Acting CFTC Commissioner Selig approved Kalshi's request as the sole confirmed commissioner on the five-member CFTC, with the agency's order reportedly mirroring Kalshi's own regulatory framework reasoning.
- • The approval creates competitive pressure on established exchanges and triggers immediate regulatory and legal challenges regarding contract classification and supervisory jurisdiction over perpetual derivatives in U.S. markets.
Summary
The Commodity Futures Trading Commission granted Kalshi, a prediction markets platform, approval to list perpetual futures contracts on Bitcoin (BTCPERP), representing a landmark regulatory decision that permits perpetual derivatives trading in the United States for the first time. Kalshi submitted its contract application pursuant to Commission Regulation 40.3 on May 28, 2026, and secured approval from acting CFTC Commissioner Selig, who served as the sole confirmed commissioner at the time of the decision. According to Kalshi's statement, the CFTC's approval order closely aligned with the company's own regulatory characterization of the product.
The market response was swift and substantial. Kalshi reported crossing $1 billion in trading volume within one week of launching perpetual futures in the U.S. market, signaling robust institutional and retail demand for this derivatives vehicle. The rapid uptake underscores investor appetite for perpetual contracts—leveraged financial instruments that allow speculators to maintain leveraged positions on underlying asset prices without traditional expiration dates.
However, the approval has triggered immediate legal action from CME Group, the dominant player in U.S. derivatives trading. CME filed suit against the CFTC, challenging the regulatory classification of perpetual futures as futures contracts rather than swaps. CME CEO Terrence Duffy argued that perpetual contracts should be treated as swaps under the Dodd-Frank Act, a designation that would impose different compliance, clearing, and reporting requirements. CME's challenge reflects competitive concerns about market share erosion and regulatory precedent in an increasingly competitive derivatives landscape.
The regulatory dispute centers on contract classification and supervisory jurisdiction. As a Designated Contract Market (DCM), Kalshi is authorized to trade futures, swaps, and options on commodities under CFTC oversight. The agency's decision to approve perpetual contracts as futures rather than swaps sidesteps more stringent swap dealer requirements and central clearing mandates, potentially lowering operational barriers for Kalshi relative to traditional swap execution models. This classification choice will likely determine the outcome of CME's litigation and establish precedent for future perpetual derivatives approvals in U.S. markets.
The market response was swift and substantial. Kalshi reported crossing $1 billion in trading volume within one week of launching perpetual futures in the U.S. market, signaling robust institutional and retail demand for this derivatives vehicle. The rapid uptake underscores investor appetite for perpetual contracts—leveraged financial instruments that allow speculators to maintain leveraged positions on underlying asset prices without traditional expiration dates.
However, the approval has triggered immediate legal action from CME Group, the dominant player in U.S. derivatives trading. CME filed suit against the CFTC, challenging the regulatory classification of perpetual futures as futures contracts rather than swaps. CME CEO Terrence Duffy argued that perpetual contracts should be treated as swaps under the Dodd-Frank Act, a designation that would impose different compliance, clearing, and reporting requirements. CME's challenge reflects competitive concerns about market share erosion and regulatory precedent in an increasingly competitive derivatives landscape.
The regulatory dispute centers on contract classification and supervisory jurisdiction. As a Designated Contract Market (DCM), Kalshi is authorized to trade futures, swaps, and options on commodities under CFTC oversight. The agency's decision to approve perpetual contracts as futures rather than swaps sidesteps more stringent swap dealer requirements and central clearing mandates, potentially lowering operational barriers for Kalshi relative to traditional swap execution models. This classification choice will likely determine the outcome of CME's litigation and establish precedent for future perpetual derivatives approvals in U.S. markets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.